Judy Ways

Judy Ways, Ph.D., Vice President of Regulatory Affairs, has 30 years of regulatory and quality experience in the areas of respiratory, inflammation, and neurology. She has a strong track record for the US and worldwide approvals for first-in-kind devices. She was previously VP Regulatory at Neuronetics, Neuron Therapeutics, and MedImmune, and in leadership roles at Aventis Behring and Glaxo.

Judy obtained her PhD. in Immunology and Cancer Biology from Stanford University.